Overview

A Phase I Topotecan Study in Subjects With Cancer and Impaired Renal Function

Status:
Completed
Trial end date:
2012-02-06
Target enrollment:
Participant gender:
Summary
To determine the effect of renal impairment and prior platinum-based chemotherapy on the safety and blood levels of topotecan administered orally
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Topotecan